Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Ready to Discuss Your Weight Management Options
doi:10.1001/jama.2026.0035 3
Treatments are provided under the supervision of board-certified practitioners with expertise in aesthetic medicine, longevity, and peptide therapies
Instead, CMS is extending the duration of a separate short-term program, called the Medicare GLP-1 Bridge, which was originally scheduled to run from July-December 2026 but will now run through the end of 2027
The GLP-1 receptor agonist drug class became a household name almost overnight thanks to the success of Novo Nordisk's semaglutide, marketed as Wegovy for weight loss and more recently as Ozempic for type 2 diabetes
:max_bytes(150000):strip_icc():focal(644x399:646x401)/Ozempic-injection-101822-f89ffa28671841cdb26ddb53f2b48803.jpg)
